STORM

is an England-based biotechnology company that develops novel therapies for the treatment of cancer, viral infections, and CNS diseases...
Read more
STORM President & CEO: Jerry McMahon

President & CEO

Jerry McMahon

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$125.2M

STORM Competitors

1Redx Pharma
2Destiny
3Argonaut Therapeutics
4CNS Pharmaceuticals
5NexImmune
6Corvus
7Altor BioScience
8Juno Therapeutics
9Mustang Bio
10Novartis

Trending Companies